MedTrace Logo

Sinolpan® Pharmacy Non-interventional Study - Quality of Live

NCT04703673 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2022-10-12

No results posted yet for this study

Summary

This non-interventional study investigates the Quality of Life of patients suffering from rhinosinusitis. Patients who seek advice in a pharmacy and choose to intake Sinolpan® or Sinolpan® forte or to use nasally applied α-sympathomimetics can participate in this anonymous patient survey.

Conditions

  • Rhinosinusitis Acute
  • Rhinosinusitis Chronic
  • Bronchitis

Interventions

DRUG

Cineole

self administration according to directions for use

DRUG

Nasal Decongestant

self administration according to directions for use

Sponsors & Collaborators

  • ClinCompetence Cologne GmbH

    collaborator UNKNOWN

  • Engelhard Arzneimittel GmbH & Co.KG

    lead INDUSTRY

Principal Investigators

  • Ralph Mösges, Prof · ClinCompetence Cologne GmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-08
Primary Completion
2022-04-30
Completion
2022-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04703673 on ClinicalTrials.gov